CODX vs TYL · rev $3.9M vs P/E 89, rev $2.14B
Co-Diagnostics, Inc. Common Stock (CODX) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported TYL revenue for 2024-12-31 was $2.14B. Net income was $263.0M. Revenue was up 9.5% from 2023-12-31 to 2024-12-31. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
CODX currently screens at market cap $31.4M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the CODX and TYL stock pages for the full models.
Not investment advice.